1-4 of 4
Frank Giles, MD MB, FRCPI, FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

GATA2 Expression Level in Chronic Myeloid Leukemia (CML) Patients Correlates with Their Prognostic Scores and Is Associated with Disease Stage at Diagnosis

Philippe Guardiola, MD, Corentin Orvain, Nick C.P. Cross, PhD, Martine Gardembas, MD, Marc Spentchian, MD, Estelle Pedrono, PhD, Diane Lambert, PhD, Anne Coutolleau, Anne Bouvier, MD, Odile Blanchet, MDPhD, Nicole Piard, MD, Norbert Ifrah, MD PhD, Frank Giles, MD MB, FRCPI, FRCPath, Andreas Hochhaus, MD, Jerald P. Radich, MD, Philippe Rousselot, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2768.
https://doi.org/10.1182/blood.V126.23.2768.2768
Published: 2015
Journal Articles

Bone Marrow (BM) Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Treated with Nilotinib

Santa Errichiello, PhD, Simona Caruso, Concetta Quintarelli, PhD, Biagio De Angelis, PhD, Novella Pugliese, MD, Roberta Della Pepa, Barbara Izzo, Luigia Luciano, MD, Simona Soverini, Carolina Terragna, PhD, Giovanni Martinelli, Daniela Cilloni, MD PhD, Giuseppe Saglio, Mario Annunziata, MD, Giovanni Caocci, Luciano Levato, MD, Emilio Usala, MD, Massimo Breccia, MD, Angelo Michele Carella, Nicola Cascavilla, MD, Mariella D'Adda, MD, Claudia Galimberti, Frank Giles, MD MB, FRCPI, FRCPath, Andreas Hochhaus, MD, Fabrizio Pane, MD
Journal: Blood
Blood (2015) 126 (23): 1570.
https://doi.org/10.1182/blood.V126.23.1570.1570
Published: 2015
Journal Articles

The Signature Program, a Distinctive Tissue Agnostic Trial Model for Molecularly Pre-Selected Hematological and Solid Tumor Patients

Frank Giles, MD MB, FRCPI, FRCPath, Sarina A. Piha-Paul, MD, Alexander I. Spira, PhD MD FACP, Fadi Braiteh, MD CPI, Julio Antonio Peguero, MD, Daniel L. Spitz, MD FACP, James A. Knost, MD, Lee Schwartzberg, MD FACP, Steven Stein, MD, August J. Salvado, MD, Claudia Lebedinsky, MD, Barinder Kang, PhD, Eric Slosberg, PhD
Journal: Blood
Blood (2014) 124 (21): 4818.
https://doi.org/10.1182/blood.V124.21.4818.4818
Published: 2014
Journal Articles

Nilotinib 300 Mg Twice Daily Is Effective and Well Tolerated as First Line Treatment of Ph-Positive Chronic Myeloid Leukemia in Chronic Phase: Preliminary Results of the ICORG 0802 Phase 2 Study.

Michael C O'Dwyer, MD, FRCPI, FRCPath, Emma Kent, Michael Parker, BSc, MSc, CStat, CMath, Ronan T. Swords, M.D., Frank Giles, MD, MB, FRCPI, FRCPath, Philipp le Coutre, MD, Swaminathan Padmanabhan, MD, MBBS, Brian Moulton, Ph.D, Mary Frances McMullin, Stephen Langabeer, PhD, Karine Egan, Ph.D, Eibhlin Conneally, MB, MRCP, MRCPath, PhD
Journal: Blood
Blood (2009) 114 (22): 3294.
https://doi.org/10.1182/blood.V114.22.3294.3294
Published: 2009